Of course the ChatGPT dog cancer vaccine spawned a startup
The Verge·1 min read
That hasn’t stopped the idea from attracting support. The startup is backed by storied tech incubator Y Combinator and says it is recruiting for its first clinical trials in Australia, with a waitlist open everywhere else (though Conyngham says they’re “accepting cases globally.”). On a section on its website aimed at veterinarians, Gamgee touts a roughly 75 per cent tumor reduction in its “first documented case,” while promising to require less than 20 minutes of a veterinarian’s time, no new clinical workflows, and a finished “vaccine in hand” in around four weeks. The company cautions that this timeline is based on a single case and may vary. Costs aren’t disclosed on the site.
